PL
PL · PL · PL-100511402
Elahere
ATC L01FX26
Last synced from URPL (Poland) on
Identification
ManufacturerAbbVie Deutschland GmbH & Co. KG
CountryPL (PL)
ATC codeL01FX26
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 1
- gtin08054083029306
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "5 mg/ml",
"packaging": "08054083029306 ¦ Rpz ¦ EU/1/24/1866/001 ¦ 159831\n1 fiol. 20 ml",
"substance": "Mirvetuximabum soravtansinum 5 mg/ml",
"common_name": "Mirvetuximabum soravtansinum",
"pl_product_id": "100511402",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code L01FX26.
- 🇨🇭ElahereAbbVie AG
- NOElahereAbbVie Deutschland GmbH & Co
- FIELAHEREAbbVie Deutschland GmbH&Co.KG
- DKELAHEREAbbVie Deutschland GmbH & Co. KG
- 🇺🇸ELAHEREImmunoGen, Inc.
- CZELAHEREAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- ISELAHEREAbbVie Deutschland GmbH & Co. KG
- GBElahere 100mg/20ml concentrate for solution for infusion vialsAbbVie Ltd
Access this data programmatically
Query Elahere and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.